Should we use GLP-1 drugs to treat obesity in children?
Children as young as 8 in the US are being prescribed off-label GLP-1 weight-loss drugs, sparking debate about the potential long-term health effects
Read the full story at New Scientist ↗
ImpactNotable 30/100
Why it mattersRule-based estimate: no strong signals; trust 7/10.
RegionsGlobal
Published4 h ago (Tue, 22 Sep 2026 11:00:00 GMT)
RetrievedTue, 22 Sep 2026 11:00:51 GMT via rss
ClassifiedTue, 22 Sep 2026 11:01:08 GMT by heuristic
AuthorAlice Klein